Prestige BioPharma Limited
KSE:950210.KS
Overview | Financials
Company Name | Prestige BioPharma Limited |
Symbol | 950210.KS |
Currency | KRW |
Price | 17,150 |
Market Cap | 1,030,649,058,250 |
Dividend Yield | 0% |
52-week-range | 7,610 - 20,900 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. So-Yeon Park |
Website | https://www.prestigebiopharma.com |
An error occurred while fetching data.
About Prestige BioPharma Limited
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD